Mediclinic Group is aware of a fake social media post that is being circulated requesting users to engage with a Medical Feedback Reward Survey. Mediclinic has not circulated any such survey. The social media post has not been published by Mediclinic. Mediclinic advises that people do not engage with the survey or respond. We release all our official communications on our website and our official social media channels which are listed on the website’s footer.
Recognition, multidisciplinary clinical approaches and management of genetic, malformative, inherited and rare (isolated and syndromic) conditions
Genetic databases (Orphanet, NCBI, OMIM, Gene tests, Face2gene, Franklin) and clinical interpretation of Microarray and NGS results (panels, clinical exomes and WES)
work up for multidisciplinary diagnostics of Genetic and Rare Diseases (both clinical and molecular). In all branches including: Cardio-Genetics, Vascular-Genetics, Neuro-Genetics, Nephro-Genetics, Onco Genetics, Pediatric-Genetics, growth disorders and delayed developmental milestones (intellectual disability and autism), Syndromology, and Metabolic Diseases.
Profile
Nationality
Italian
Summary
Dr. Anwar Baban is a highly experienced and respected Consultant in Clinical Genetics and Genomics with an impressive more than 20 years of experience in the field. Her career is characterised by deep expertise, significant leadership roles and a profound commitment to patient and family well-being. She currently serves as the Head of Department Clinical Molecular Genetics and Precision Medicine at Mediclinic Middle East. This leadership position highlights her strategic importance in establishing and guiding Mediclinic's advanced genetics and precision medicine services. She is also the Founder and Lead of the Cardio-Genetic Center, demonstrating her initiative and specialisation in a critical area of genetic medicine.
Prior to joining Mediclinic, she was a fully recognised Consultant in Clinical Genetics and Genomics at the prestigious Bambino Gesù Children Hospital and Research Institute in Rome, Italy. This institution is recognised as a leading hospital at both Italian and European levels, affirming her experience within a top-tier academic and clinical environment.
Dr. Anwar holds a PhD in Genetics and a specialisation degree in Medical Genetics, providing a robust academic and clinical foundation for her expertise. She also holds the "Abilitazione Scientifica Nazionale" (National Scientific Qualification) for Associate Professor in Italy, recognising her research contributions within the Italian university system.
Her core expertise lies in the evaluation and management of families with suspected or established genetic, inherited, metabolic, and rare diseases. Her extensive knowledge spans various genetic conditions, with a strong focus on:
o Cardiogenetics: Including cardiomyopathies, congenital heart diseases, genetically determined arrhythmias, and aortopathies – directly relevant to the "Sudden Death" project.
o Paediatric Genetics: Reflecting her background in a leading children's hospital.
o Syndromology and Dysmorphology: Expertise in diagnosing complex genetic syndromes with characteristic physical features.
o Neurogenetics, Nephrogenetics, and Oncogenetics: Demonstrating her versatility across multiple organ systems and disease areas.
Dr. Anwar is also proficient in the clinical interpretation of all diagnostic genetic testing, including::
o Microarray
o Next-Generation Sequencing (NGS) results, encompassing panels, clinical exomes, and Whole Exome Sequencing (WES)
o Triplet repeat expansion conditions
o Pharmacogenomics (the study of how genes affect a person's response to drugs).
She is actively involved in numerous multicentric and funded projects, showcasing her capacity for collaborative and impactful research. She serves as a board member of the European Reference Network for Rare Diseases (ERN) and co-Chair for the Genetics Working Group of the Association of European Pediatric Cardiology. Her significant scientific contributions are evidenced by her h-index of 26 and over 104 publications on PubMed, reflecting a substantial and impactful body of work, and she is a respected voice in the field, acting as a reviewer and editor for several prestigious medical journals and an invited speaker at international conferences.
Dr. Anwar is characterised by her profound passion for patient care. She is dedicated to family empowerment through shared decision-making and informed decisions, ensuring that families are active, understanding partners in managing complex genetic diagnoses.
Qualification
Medical Registration at Order of Doctors in Rome - ITALY: M58296
PhD Degree - University of Genoa – Italy.
Specialization degree in Medical Genetics University of Genoa – Italy.
Medicine and Surgery (MBChB) University of Baghdad – Iraq.
Contact
Practices at
Mediclinic City Hospital
Consultant Clinical Genetics and Genomics In department Clinical Molecular Genetics and Precision Medicine
